Patents by Inventor Hila Benjamin

Hila Benjamin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190300963
    Abstract: The present invention provides a method for classification of thyroid tumors through the analysis of the expression patterns of specific microRNAs in fine needle aspiration samples. Thyroid tumor classification according to a microRNA expression signature allows optimization of diagnosis and treatment, as well as determination of signature-specific therapy.
    Type: Application
    Filed: November 15, 2018
    Publication date: October 3, 2019
    Applicant: ROSETTA GENOMICS LTD.
    Inventors: Zohar Barnett-Itzhaki, Gila Lithwick Yanai, Eti Meiri, Yael Spector, Hila Benjamin, Nir Dromi
  • Patent number: 9914972
    Abstract: The present invention provides specific nucleic acid sequences for use in the identification, classification and diagnosis of various sub-types of lung cancers. The present invention permits one to accurately classify lung cancers based on their miR expression profile without further manipulation. Using microRNA microarray data generated from over two hundred formalin-fixed paraffin-embedded (FFPE) resection samples, fine needle aspiration (FNA) samples and fine needle biopsy (FNB) samples of primary lung cancer, microRNA expression profiles were identified that differ significantly for various sub-types of lung cancer.
    Type: Grant
    Filed: March 26, 2012
    Date of Patent: March 13, 2018
    Assignee: ROSETTA GENOMICS LTD.
    Inventors: Gila Lithwick Yanai, Hila Benjamin
  • Publication number: 20170356055
    Abstract: The present invention provides a method for classification of thyroid tumors through the analysis of the expression patterns of specific microRNAs in fine needle aspiration samples. Thyroid tumor classification according to a microRNA expression signature allows optimization of diagnosis and treatment, as well as determination of signature-specific therapy.
    Type: Application
    Filed: June 16, 2017
    Publication date: December 14, 2017
    Inventors: Zohar Barnett-Itzhaki, Gila Lithwick Yanai, Eti Meiri, Yael Spector, Hila Benjamin, Nir Dromi
  • Patent number: 9834821
    Abstract: The present invention provides nucleic acid sequences that are used for identification, classification and diagnosis of specific types of cancers. The nucleic acid sequences can also be used for prognosis evaluation of a subject based on the expression pattern of a biological sample.
    Type: Grant
    Filed: January 8, 2015
    Date of Patent: December 5, 2017
    Assignee: ROSETTA GENOMICS LTD.
    Inventors: Ranit Aharonov, Nitzan Rosenfeld, Hila Benjamin
  • Patent number: 9708667
    Abstract: The present invention provides a method for classification of thyroid tumors through the analysis of the expression patterns of specific microRNAs in fine needle aspiration samples. Thyroid tumor classification according to a microRNA expression signature allows optimization of diagnosis and treatment, as well as determination of signature-specific therapy.
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: July 18, 2017
    Assignee: ROSETTA GENOMICS, LTD.
    Inventors: Gila Lithwick Yanai, Eti Meiri, Yael Spector, Hila Benjamin, Nir Dromi
  • Publication number: 20170016076
    Abstract: The present invention provides a method for classification of thyroid tumors through the analysis of the expression patterns of specific microRNAs in fine needle aspiration samples. Thyroid tumor classification according to a microRNA expression signature allows optimization of diagnosis and treatment, as well as determination of signature-specific therapy.
    Type: Application
    Filed: August 15, 2016
    Publication date: January 19, 2017
    Inventors: Zohar Barnett-Itzhaki, Gila Lithwick Yanai, Eti Meiri, Yael Spector, Hila Benjamin, Nir Dromi
  • Patent number: 9133522
    Abstract: The present invention provides nucleic acid sequences that are used for identification and diagnosis of specific cancers. The nucleic acid sequences can also be used for prognosis evaluation of a subject based on the expression profile of a biological sample.
    Type: Grant
    Filed: October 29, 2008
    Date of Patent: September 15, 2015
    Assignee: Rosetta Genomics Ltd.
    Inventors: Shai Rosenwald, Hila Benjamin, Nitzan Rosenfeld
  • Publication number: 20150126399
    Abstract: The present invention provides nucleic acid sequences that are used for identification, classification and diagnosis of specific types of cancers. The nucleic acid sequences can also be used for prognosis evaluation of a subject based on the expression pattern of a biological sample.
    Type: Application
    Filed: January 8, 2015
    Publication date: May 7, 2015
    Inventors: Ranit Aharonov, Nitzan Rosenfeld, Hila Benjamin
  • Publication number: 20140309123
    Abstract: The present invention provides specific nucleic acid sequences for use in the identification, classification and diagnosis of various sub-types of lung cancers. The present invention permits one to accurately classify lung cancers based on their miR expression profile without further manipulation. Using microRNA microarray data generated from over two hundred formalin-fixed paraffin-embedded (FFPE) resection samples, fine needle aspiration (FNA) samples and fine needle biopsy (FNB) samples of primary lung cancer, microRNA expression profiles were identified that differ significantly for various sub-types of lung cancer.
    Type: Application
    Filed: March 26, 2012
    Publication date: October 16, 2014
    Applicant: Rosetta Genomics Ltd.
    Inventors: Gila Lithwick Yanai, Hila Benjamin
  • Patent number: 8563252
    Abstract: The present invention provides nucleic acid sequences that are used for identification, classification and diagnosis of specific types of nonsmall-cell lung cancers (NSCLC). The nucleic acid sequences can also be used for prognosis evaluation of a subject based on the expression pattern of a biological sample.
    Type: Grant
    Filed: August 31, 2009
    Date of Patent: October 22, 2013
    Assignee: Rosetta Genomics Ltd.
    Inventors: Ranit Aharonov, Nitzan Rosenfeld, Shai Rosenwald, Hila Benjamin
  • Publication number: 20120064520
    Abstract: The present invention provides nucleic acid sequences that are used for identification, classification and diagnosis of specific types of cancers. The nucleic acid sequences can also be used for prognosis evaluation of a subject based on the expression pattern of a biological sample.
    Type: Application
    Filed: February 28, 2008
    Publication date: March 15, 2012
    Inventors: Ranit Aharonov, Nitzan Rosenfeld, Hila Benjamin
  • Publication number: 20110071215
    Abstract: Described herein are compositions and methods for the diagnosis and treatment of mesothelioma patients and the prognosis of mesothelioma patients after surgical operation. Specifically the invention relates to microRNA molecules associated with diagnosis, treatment and prognosis of mesothelioma, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Application
    Filed: May 26, 2009
    Publication date: March 24, 2011
    Inventors: Harvey Pass, Hila Benjamin, Moshe Hoshen, Sergey Ivanov
  • Publication number: 20100323903
    Abstract: The present invention provides nucleic acid sequences that are used for identification and diagnosis of specific cancers. The nucleic acid sequences can also be used for prognosis evaluation of a subject based on the expression profile of a biological sample.
    Type: Application
    Filed: October 29, 2008
    Publication date: December 23, 2010
    Inventors: Shai Rosenwald, Hila Benjamin, Nitzan Rosenfeld
  • Publication number: 20100047804
    Abstract: The present invention provides nucleic acid sequences that are used for identification, classification and diagnosis of specific types of nonsmall-cell lung cancers (NSCLC). The nucleic acid sequences can also be used for prognosis evaluation of a subject based on the expression pattern of a biological sample.
    Type: Application
    Filed: August 31, 2009
    Publication date: February 25, 2010
    Inventors: Ranit AHARONOV, Nitzan Rosenfeld, Shai Rosenwald, Hila Benjamin
  • Publication number: 20090186353
    Abstract: Described herein are polynucleotides associated with specific types of cancers. The polynucleotides are miRNAs, miRNA precursors, and associated nucleic acids. Methods and compositions are described that can be used for diagnosis, prognosis, and treatment of various cancers.
    Type: Application
    Filed: May 4, 2007
    Publication date: July 23, 2009
    Inventors: Ranit Aharonov, Nitzan Rosenfeld, Hila Benjamin